---
title: "Medtronic’s Prevail DCB to be studied in US IDE trial"
date: "2024-10-23T14:55:21.000Z"
publishedDate: "23 octobre 2024"
summary: "Medtronic has received approval of a US Food and Drug Administration (FDA) investigational device exemption (IDE) to initiate its pivotal clinical trial of the Prevail coronary paclitaxel drug-coated balloon (DCB) for in stent restenosis (ISR) and de novo small vessel disease. Data from the Prevail Global Clinical Program will be used to support approval of [&#8230;] The post Medtronic’s Prevail DCB to be studied in US IDE trial appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/medtronics-prevail-dcb-to-be-studied-in-us-ide-trial/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-10-23-medtronics-prevail-dcb-to-be-studied-in-us-ide-trial"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/10/balloon-1600x1000-1.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/medtronics-prevail-dcb-to-be-studied-in-us-ide-trial/"
---

![Medtronic’s Prevail DCB to be studied in US IDE trial](https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/10/balloon-1600x1000-1.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/medtronics-prevail-dcb-to-be-studied-in-us-ide-trial/*

## L’essentiel

Medtronic has received approval of a US Food and Drug Administration (FDA) investigational device exemption (IDE) to initiate its pivotal clinical trial of the Prevail coronary paclitaxel drug-coated balloon (DCB) for in stent restenosis (ISR) and de novo small vessel disease. Data from the Prevail Global Clinical Program will be used to support approval of [&#8230;] The post Medtronic’s Prevail DCB to be studied in US IDE trial appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/medtronics-prevail-dcb-to-be-studied-in-us-ide-trial/
